ARTICLE | Product Development
Feb. 22 Quick Takes: Sanofi, J&J in COVID vaccine manufacturing deal; plus AZ, Regeneron-Sanofi, Incyte, Ascletis, Novo-Altasciences, Regor
February 23, 2021 2:23 AM UTC
Sanofi (Euronext:SAN; NASDAQ:SNY) will formulate and fill about 12 million doses per month of the single-shot COVID-19 vaccine from Johnson & Johnson (NYSE:JNJ) following authorization. The candidate is under FDA and EMA review.
Sanofi is already producing more than 125 million doses of Comirnaty for Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX), and will continue to develop its own COVID-19 vaccine programs with partners GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Translate Bio Inc. (NASDAQ:TBIO). ...